Table 1.
Control | Early-Onset AD | Late-Onset AD | |
---|---|---|---|
Sex | 12 M/14 F | 7 M/9 F | 8 M/10 F |
Age (years) | |||
M | 70.7 ± 9.85 | 63.1 ± 5.61 | 82.9 ± 5.38* |
F | 70.8 ± 14.8 | 54.2 ± 7.16* | 83.4 ± 6.35 |
PMI (hours) | |||
M | 16.7 ± 8.50 | 25.2 ± 10.6 | 22.7 ± 8.54 |
F | 21.7 ± 12.7 | 18.5 ± 9.87 | 20.4 ± 7.98 |
Brain weight (grams) | |||
M | 1275 ± 155.1 | 1157 ± 139.2 | 1126 ± 98.9* |
F | 1191 ± 108.6 | 879.4 ± 143.4*** | 992.0 ± 94.9* |
The brain samples analyzed for soluble Aβ peptides were obtained from neurologically normal cases (Control) and from histopathologically confirmed cases of Early-Onset or Late-Onset Alzheimer disease (AD). M, male; F, female; years (time-at-death; age at autopsy); PMI, post-mortem interval; *P < 0.05; ***P < 0.001; vs. control donors (mean ± sem).